TotalMarketCap

Cumberland Pharmaceuticals

CPIXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$75.515 M

$5.04 +13.51%

Close of 6 Nov 2026

As of 6 Nov 2026, Cumberland Pharmaceuticals (CPIX) has a market capitalization of $75.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$44.5M

#2753 by revenue

Earnings

-$2.84M

Loss-making

Shares outstanding

14,983,107

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #304Tiziana Life SciencesTLSA$79.3M
  2. #305Tonix PharmaceuticalsTNXP$79.0M
  3. #306Cumberland PharmaceuticalsCPIX$75.5M
  4. #307MedicinovaMNOV$71.9M
  5. #308Rani TherapeuticsRANI$71.7M

What if Cumberland Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,884,581

Per share 373,925× higher

Bitcoin $1.53T

$101,971.38

Per share 20,232× higher

Apple $5.02T

$334,762.52

Per share 66,421× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Cumberland Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.